Thomas S Mchugh - Net Worth and Insider Trading
Thomas S Mchugh Net Worth
The estimated net worth of Thomas S Mchugh is at least $1 Million dollars as of 2024-05-01. Thomas S Mchugh is the CFO of Avadel Pharmaceuticals PLC and owns about 80,500 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $1 Million. Details can be seen in Thomas S Mchugh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas S Mchugh has not made any transactions after 2024-01-16 and currently still holds the listed stock(s).
Transaction Summary of Thomas S Mchugh
Thomas S Mchugh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas S Mchugh owns 2 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , and Huttig Building Products Inc (HBP) .
Click here to see the complete history of Thomas S Mchugh’s form 4 insider trades.
Insider Ownership Summary of Thomas S Mchugh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2024-01-16 | Chief Financial Officer |
| HBP | Huttig Building Products Inc | 2003-09-15 | Vice President of Finance&CFO |
Thomas S Mchugh Latest Holdings Summary
Thomas S Mchugh currently owns a total of 1 stock. Thomas S Mchugh owns 80,500 shares of Avadel Pharmaceuticals PLC (AVDL) as of January 16, 2024, with a value of $1 Million.
Latest Holdings of Thomas S Mchugh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2024-01-16 | 80,500 | 18.16 | 1,461,880 |
Holding Weightings of Thomas S Mchugh
Thomas S Mchugh Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas S Mchugh has made a total of 7 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Avadel Pharmaceuticals PLC is the acquisition of 2,000 shares on January 16, 2024, which cost Thomas S Mchugh around $29,000.
Insider Trading History of Thomas S Mchugh
- 1
Thomas S Mchugh Trading Performance
GuruFocus tracks the stock performance after each of Thomas S Mchugh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas S Mchugh is 29.33%. GuruFocus also compares Thomas S Mchugh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas S Mchugh within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas S Mchugh's insider trading performs compared to the benchmark.
Performance of Thomas S Mchugh
Average Return
110.85%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.39 | 29.33 | 64 | 110.85 | -4.89 | 25.1 |
| Relative Return to S&P 500(%) | -13.81 | 25.71 | 54.38 | 88.71 | -14.31 | 15.7 |
Thomas S Mchugh Ownership Network
Ownership Network List of Thomas S Mchugh
Ownership Network Relation of Thomas S Mchugh
Thomas S Mchugh Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Thomas S Mchugh is the Chief Financial Officer of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include director & Chief Executive Officer Greg J Divis , Chief Commercial Officer Richard J Kim , and Chief Medical Officer Douglas J Williamson .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Thomas S Mchugh made 3 insider transaction in Avadel Pharmaceuticals PLC (AVDL) with a net purchase of 9,000. Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 33,000 shares made by Eric J Ende , and a net purchase of 4,500 shares made by Linda Palczuk .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 70,500 shares were bought by its insiders, resulting in a net sale of 33,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Thomas S Mchugh Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas S Mchugh. You might contact Thomas S Mchugh via mailing address: 2280 Schuetz Road, St. Louis Mo 63146.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
